tenofovir has been researched along with Liver Failure in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 4 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furquim d'Almeida, A; Ho, E; Van Hees, S; Vanwolleghem, T | 1 |
| Agarwal, K; Berg, T; Biermer, M; Carey, I; Lok, J; Lonjon-Domanec, I; Shivkar, Y | 1 |
| Chan, HL; Chan, SL; Choi, J; Le, A; Lim, YS; Liu, K; Nguyen, MH; Wong, GL; Wong, VW; Yip, TC | 1 |
| Ahn, SH; Chan, HL; Lee, HW; Lui, GC; Tse, YK; Wong, GL; Wong, VW; Yip, TC | 1 |
| Chang, WY; Chen, DS; Chen, PJ; Cheng, PN; Chiu, FW; Chiu, YC; Hsu, YC; Kao, JH; Liu, CH; Liu, CJ; Su, TH; Tseng, TC; Yang, HC; Yang, SS | 1 |
| Abraham, I; Chacra, W; Danciu, OC; Kankanala, V; Remo, M | 1 |
| Bang, SJ; Jeong, ID; Jung, SW; Kim, BG; Lee, BU; Lee, H; Lee, SB; Park, JH; Park, NH; Shin, JW | 1 |
| Price, J | 1 |
| Rao, W; Shen, Z; Xie, M | 1 |
| Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J | 1 |
| Gómez Espín, R; Muñoz Bertrán, E; Ortega González, I; Pérez Ceballos, E | 1 |
| Hosseini, SH; Kohler, JJ | 1 |
| Cholongitas, E; Papatheodoridis, GV | 1 |
| Gutiérrez, F; Masiá, M; Padilla, S; Pascual, J; Ramos, JM | 1 |
| Bruno, R; Filice, G; Sacchi, P | 1 |
| Cooper, DA; Dore, GJ; Matthews, GV | 1 |
5 review(s) available for tenofovir and Liver Failure
| Article | Year |
|---|---|
Clinical management of chronic hepatitis B: A concise overview.
Topics: Aged; Antiviral Agents; Asymptomatic Diseases; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Esophageal and Gastric Varices; Hepatic Encephalopathy; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Liver Neoplasms; Male; Seroconversion; Tenofovir; Withholding Treatment | 2022 |
An update on hepatitis B, D, and E viruses.
Topics: Adenine; Drug Therapy, Combination; Guanine; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis E; Humans; Interferon-alpha; Liver Cirrhosis; Liver Failure; Organophosphonates; Tenofovir; Treatment Outcome | 2014 |
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
Topics: Adenine; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Specificity; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Fatal Outcome; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunologic Factors; Immunotherapy; Liver Failure; Lymphoma, B-Cell, Marginal Zone; Male; Organophosphonates; Prednisone; Recurrence; Rituximab; Tenofovir; Vincristine; Virus Activation | 2010 |
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.
Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver Failure; Liver Transplantation; Nucleotides; Organophosphonates; Recurrence; Tenofovir; Time Factors; Treatment Outcome | 2013 |
Severe toxicity associated with the combination of tenofovir and didanosine: case report and review.
Topics: Acidosis, Lactic; Acute Disease; Adenine; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Liver Failure; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2005 |
1 trial(s) available for tenofovir and Liver Failure
| Article | Year |
|---|---|
A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV 'cure'.
Topics: Antiviral Agents; DNA, Viral; Hepatic Insufficiency; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Male; Middle Aged; Nucleosides; Tenofovir | 2022 |
10 other study(ies) available for tenofovir and Liver Failure
| Article | Year |
|---|---|
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Survival Analysis; Tenofovir; Treatment Outcome | 2019 |
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B.
Topics: Age Factors; Aged; Alanine Transaminase; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Research Design; Retrospective Studies; Serum Albumin; Survival Rate; Tenofovir; Treatment Outcome | 2020 |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antiviral Agents; DNA, Viral; Female; Guanine; Hematologic Neoplasms; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Tenofovir; Viral Load; Virus Activation; Withholding Treatment; Young Adult | 2020 |
Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report.
Topics: Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Liver Failure; Middle Aged; Paclitaxel; Tenofovir; Virus Activation | 2017 |
Mortality, liver transplantation and hepatic complications in patients with treatment-naïve chronic hepatitis B treated with entecavir vs tenofovir.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Guanine; Hepatitis B, Chronic; Humans; Korea; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Survival Analysis; Tenofovir; Treatment Outcome; Young Adult | 2018 |
Tenofovir disoproxil fumarate rescue therapy for HBV recurrence in two liver transplant recipients with previous multiple nucleo(s/t)ide treatment failures.
Topics: Adenine; Aged; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B; Humans; Liver Failure; Liver Function Tests; Liver Transplantation; Male; Nucleotides; Organophosphonates; Recurrence; Retreatment; Risk Assessment; Tenofovir; Transplant Recipients; Treatment Failure; Treatment Outcome | 2014 |
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult | 2015 |
Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment.
Topics: Adenine; Animals; Cardiomyopathies; Cell Separation; DNA, Mitochondrial; Female; HIV Infections; HIV-1; Humans; Kidney Tubules, Proximal; Lasers; Liver Failure; Male; Mice; Mice, Inbred C57BL; Microdissection; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Staining and Labeling; Tenofovir | 2011 |
Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
Topics: Adenine; Anti-HIV Agents; Humans; Liver Failure; Liver Transplantation; Organophosphonates; Severity of Illness Index; Tenofovir | 2007 |
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
Topics: Adenine; CD4 Lymphocyte Count; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Severity of Illness Index; Tenofovir; Time Factors; Treatment Outcome; Viral Load | 2007 |